by Patient Voice Initiative | Sep 3, 2019 | E, Glossary
see Economic Sub Committee (PBAC); Evaluation Sub Committee (MSAC). by Patient Voice Initiative | Sep 3, 2019 | E, Glossary
see European Medicines Agency. by Patient Voice Initiative | Sep 3, 2019 | E, Glossary
an agency of the European Union in charge of the evaluation and supervision of medicinal products. by Patient Voice Initiative | Sep 3, 2019 | E, Glossary
A subcommittee of MSAC that primarily advises MSAC on the issues and uncertainties arising from the evidence presented in an assessment report. CoA by Patient Voice Initiative | Sep 3, 2019 | E, Glossary
A subcommittee of PBAC that primarily advises PBAC on the cost-effectiveness aspects in submissions. CoA by Patient Voice Initiative | Sep 3, 2019 | E, Glossary
A means of estimating the costs and effects of a technology over periods of time or patient groups not covered in a clinical trial. HTAI by Patient Voice Initiative | Sep 3, 2019 | E, Glossary
In HTA, an economic analysis is an assessment that compares the costs and benefits of using different tests or treatments for the same condition. Sometimes called an economic evaluation. HTAI by Patient Voice Initiative | Aug 8, 2019 | E, Glossary